Travere Therapeutics, Inc.
TVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001438533
In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.98B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Travere Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 169
- −5 vs. Q1 2023
- Shares held
- 82.8M
- −1.41M (−1.7%) vs. Q1 2023
- Total value
- $1.27B
- −$620.0M (−32.8%) vs. Q1 2023
- New holders
- 26
- 83 more added
- Sold out
- 31
- 41 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $5.98B |
| Q1 2026 | 261 | $3.01B |
| Q4 2025 | 278 | $3.90B |
| Q3 2025 | 238 | $2.41B |
| Q2 2025 | 213 | $1.49B |
| Q1 2025 | 218 | $1.77B |
| Q4 2024 | 197 | $1.66B |
| Q3 2024 | 178 | $1.16B |
| Q2 2024 | 174 | $723.4M |
| Q1 2024 | 175 | $677.4M |
| Q4 2023 | 165 | $769.6M |
| Q3 2023 | 169 | $737.2M |
| Q2 2023 | 169 | $1.27B |
| Q1 2023 | 175 | $1.89B |
| Q4 2022 | 155 | $1.53B |
| Q3 2022 | 171 | $1.72B |
| Q2 2022 | 171 | $1.68B |
| Q1 2022 | 169 | $1.79B |
| Q4 2021 | 169 | $2.04B |
| Q3 2021 | 148 | $1.48B |
| Q2 2021 | 136 | $900.8M |
| Q1 2021 | 150 | $1.56B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Travere Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ensign Peak Advisors, Inc | 110,088 | $1.69M | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 113,443 | $1.74M | 0.00% | +15,542+15.9% | Added |
| Trexquant Investment LP | 120,990 | $1.86M | 0.05% | +46,106+61.6% | Added |
| Wells Fargo & Company | 122,896 | $1.89M | 0.00% | +52,518+74.6% | Added |
| UBS Asset Management Americas Inc | 88,545 | $1.99M | 0.00% | 00.0% | Unchanged |
| Natixis | 135,000 | $2.07M | 0.02% | +94,700+235.0% | Added |
| UBS Group AG | 135,322 | $2.08M | 0.00% | +9,537+7.6% | Added |
| Legal & General Group Plc | 135,538 | $2.08M | 0.00% | +10,306+8.2% | Added |
| Swiss National Bank | 137,900 | $2.12M | 0.00% | −2,800−2.0% | Reduced |
| Parkman Healthcare Partners LLC | 146,323 | $2.25M | 0.39% | +4,436+3.1% | Added |
| Squarepoint Ops LLC | 160,298 | $2.46M | 0.01% | +1,478+0.9% | Added |
| Palo Alto Investors LP | 166,069 | $2.55M | 0.21% | 00.0% | Unchanged |
| Thrivent Financial for Lutherans | 171,115 | $2.63M | 0.01% | −92,384−35.1% | Reduced |
| Twinbeech Capital LP | 171,846 | $2.64M | 0.05% | +39,218+29.6% | Added |
| Weiss Multi-Strategy Advisers LLC | 192,870 | $2.96M | 0.06% | +11,052+6.1% | Added |
| Cubist Systematic Strategies, LLC | 204,782 | $3.15M | 0.03% | +167,106+443.5% | Added |
| Sphera Funds Management Ltd. | 213,462 | $3.28M | 0.70% | +25,962+13.8% | Added |
| Phocas Financial Corp. | 223,183 | $3.43M | 0.47% | −1,080−0.5% | Reduced |
| Polar Asset Management Partners Inc. | 230,965 | $3.55M | 0.07% | −567,225−71.1% | Reduced |
| Bank of New York Mellon Corp | 248,146 | $3.81M | 0.00% | +31,377+14.5% | Added |
| Barclays PLC | 252,583 | $3.88M | 0.00% | +49,797+24.6% | Added |
| Citigroup Inc | 265,462 | $4.08M | 0.01% | −96,609−26.7% | Reduced |
| Ameriprise Financial Inc | 283,440 | $4.35M | 0.00% | −36,431−11.4% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 290,911 | $4.47M | 0.02% | +13,899+5.0% | Added |
| Panagora Asset Management Inc | 292,382 | $4.49M | 0.03% | +90,385+44.7% | Added |
| Schonfeld Strategic Advisors LLC | 305,629 | $4.69M | 0.04% | +17,871+6.2% | Added |
| Balyasny Asset Management LLC | 326,570 | $5.02M | 0.01% | +326,570 | New |
| GW&K Investment Management, LLC | 350,610 | $5.38M | 0.05% | +48,856+16.2% | Added |
| ExodusPoint Capital Management, LP | 396,060 | $6.08M | 0.07% | +396,060 | New |
| Deutsche Bank AG | 424,541 | $6.52M | 0.00% | −52,267−11.0% | Reduced |
| Sectoral Asset Management Inc | 435,313 | $6.69M | 1.11% | +76,700+21.4% | Added |
| International Biotechnology Trust PLC | 441,019 | $6.77M | 2.06% | +300,000+212.7% | Added |
| Two Sigma Investments, LP | 441,267 | $6.78M | 0.02% | −112,446−20.3% | Reduced |
| Hudson Bay Capital Management LP | 444,031 | $6.82M | 0.07% | +444,031 | New |
| Octagon Capital Advisors LP | 495,000 | $7.60M | 1.06% | 00.0% | Unchanged |
| Rafferty Asset Management, LLC | 498,252 | $7.65M | 0.04% | +171,782+52.6% | Added |
| Emerald Mutual Fund Advisers Trust | 529,518 | $8.13M | 0.44% | +529,518 | New |
| Charles Schwab Investment Management Inc | 540,353 | $8.30M | 0.00% | +38,023+7.6% | Added |
| MPM Oncology Impact Management LP | 552,846 | $8.49M | 1.71% | +239,204+76.3% | Added |
| Millennium Management LLC | 624,603 | $9.59M | 0.01% | −499,735−44.4% | Reduced |
| Emerald Advisers, LLC | 643,052 | $9.88M | 0.43% | +643,052 | New |
| Northern Trust Corp | 684,133 | $10.5M | 0.00% | −6,768−1.0% | Reduced |
| Two Sigma Advisers, LP | 684,800 | $10.5M | 0.03% | −36,800−5.1% | Reduced |
| Invesco Ltd. | 700,002 | $10.8M | 0.00% | +149,546+27.2% | Added |
| JPMorgan Chase & Co | 729,408 | $11.2M | 0.00% | −404,743−35.7% | Reduced |
| Walleye Capital LLC | 733,862 | $11.3M | 0.20% | +692,631+1,679.9% | Added |
| Finepoint Capital LP | 761,721 | $11.7M | 4.05% | −113,500−13.0% | Reduced |
| Morgan Stanley | 798,779 | $12.3M | 0.00% | −95,091−10.6% | Reduced |
| Nuveen Asset Management, LLC | 890,777 | $13.7M | 0.00% | +563,124+171.9% | Added |
| Goldman Sachs Group Inc | 923,891 | $14.2M | 0.00% | +132,663+16.8% | Added |
| Woodline Partners LP | 1,040,296 | $16.0M | 0.19% | −399,403−27.7% | Reduced |
| Assenagon Asset Management S.A. | 1,098,045 | $16.9M | 0.07% | −560,644−33.8% | Reduced |
| D. E. Shaw & Co., Inc. | 1,261,004 | $19.4M | 0.03% | +261,513+26.2% | Added |
| Bank of America Corp | 1,349,503 | $20.7M | 0.00% | +531,678+65.0% | Added |
| Geode Capital Management, LLC | 1,391,756 | $21.4M | 0.00% | +175,182+14.4% | Added |
| Kynam Capital Management, LP | 1,454,730 | $22.3M | 3.42% | −108,865−7.0% | Reduced |
| Jacobs Levy Equity Management, Inc | 1,524,800 | $23.4M | 0.13% | +59,048+4.0% | Added |
| Rock Springs Capital Management LP | 1,527,720 | $23.5M | 0.56% | +251,070+19.7% | Added |
| Renaissance Technologies LLC | 1,555,013 | $23.9M | 0.03% | −589,809−27.5% | Reduced |
| Point72 Asset Management, L.P. | 1,785,979 | $27.4M | 0.09% | +1,785,979 | New |
| Pictet Asset Management SA | 1,957,120 | $30.1M | 0.04% | +406,618+26.2% | Added |
| OrbiMed Advisors LLC | 2,118,100 | $32.5M | 0.63% | +373,800+21.4% | Added |
| Macquarie Group Ltd | 3,953,114 | $60.7M | 0.07% | +308,427+8.5% | Added |
| Vanguard Group Inc | 4,207,282 | $64.6M | 0.00% | +222,688+5.6% | Added |
| State Street Corp | 5,732,636 | $88.1M | 0.00% | +1,364,759+31.2% | Added |
| Janus Henderson Group PLC | 6,966,970 | $107.0M | 0.07% | +121,157+1.8% | Added |
| BlackRock Inc. | 7,116,918 | $109.3M | 0.00% | +1,069,002+17.7% | Added |
| Deep Track Capital, LP | 7,370,000 | $113.2M | 5.29% | +1,222,732+19.9% | Added |
| Armistice Capital, LLC | 7,450,000 | $114.4M | 2.87% | +302,000+4.2% | Added |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −4,113,962−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −1,263,721−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −984,961−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −511,784−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −422,961−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −418,520−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −254,000−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −249,569−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −214,498−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −132,005−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −116,000−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −83,857−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −69,260−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −56,400−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −35,617−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −25,606−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −19,640−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −17,909−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −16,700−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −10,766−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −9,898−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −4,793−100.0% | Sold out |
| Retirement Group, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −196−100.0% | Sold out |
| Quent Capital, LLC | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −87,275−100.0% | Sold out |